Canada markets closed

Columbia Care Inc. (CCHW.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.6900-0.0500 (-6.76%)
At close: 03:07PM EDT

Columbia Care Inc.

680 Fifth Avenue
24th Floor
New York, NY 10019
United States
212 634 7100

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Nicholas Keane VitaCo-Founder, CEO & Director846.88kN/A1973
Mr. David J. HartChief Operating Officer510.54kN/A1977
Mr. Derek WatsonChief Financial OfficerN/AN/A1971
Dr. Rosemary Mazanet M.D., Ph.D.Chief Scientific OfficerN/AN/A1956
Mr. Bryan Lamont OlsonChief People & Admin. OfficerN/AN/A1974
Ms. Lee Ann EvansVP of Investor RelationsN/AN/AN/A
Kate DriscollVP of ComplianceN/AN/AN/A
Mr. David SirollyChief Legal Officer & Gen. CounselN/AN/A1975
Mr. Bryant IsonChief Marketing OfficerN/AN/AN/A
Mr. Guy Jacques HussussianChief Data OfficerN/AN/A1967
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Columbia Care Inc. engages in cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was founded in 2012 and is headquartered in New York, New York.

Corporate Governance

Columbia Care Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.